Bart Lutterbach

Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors

Erick J. Morris, Sharda Jha, Clifford R. Restaino et al. · Cancer Discovery · 2013 · 685 citations · Full text

Medicine, Oncology, Pharmacology +17

ETO, a Target of t(8;21) in Acute Leukemia, Interacts with the N-CoR and mSin3 Corepressors

Bart Lutterbach, Jennifer J. Westendorf, Bryan Linggi et al. · Molecular and Cellular Biology · 1998 · 440 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

ETO, a Target of t(8;21) in Acute Leukemia, Makes Distinct Contacts with Multiple Histone Deacetylases and Binds mSin3A through Its Oligomerization Domain

Joseph M. Amann, John Nip, David K. Strom et al. · Molecular and Cellular Biology · 2001 · 339 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Lung Cancer Cell Lines Harboring <i>MET</i> Gene Amplification Are Dependent on Met for Growth and Survival

Bart Lutterbach, Qinwen Zeng, Lenora J. Davis et al. · Cancer Research · 2007 · 320 citations

Medicine, Molecular Biology, Oncology +17

<i>FGFR2</i> -Amplified Gastric Cancer Cell Lines Require FGFR2 and Erbb3 Signaling for Growth and Survival

Kaiko Kunii, Lenora J. Davis, Julie Gorenstein et al. · Cancer Research · 2008 · 269 citations

Medicine, Oncology, Pharmacology +17